Back to AL Alphabet Inc.

LYELLYEL
Showing 8 of 14 quarters

Position history for ALAlphabet Inc.'s holdings in LYELL IMMUNOPHARMA INC

Alphabet Inc. holds 293,256 shares of LYEL (LYELL IMMUNOPHARMA INC), worth $5.9M as of 2026-Q1. LYEL represents 0.1% of Alphabet Inc.'s portfolio.

Current Value

$5.9M

Current Shares

293,256

Total Value Change

-$2.6M

Total Shares Change

-5.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Unchanged
293,256
0.0%
$5.9M0.1%$23.33
0
2025-Q4
Unchanged
293,256
0.0%
$9M0.3%$31.59
0
2025-Q3
Unchanged
293,256
0.0%
$4.8M0.2%$14.97
0
2025-Q2
Decreased
293,256
-95.0%
$2.6M0.1%$8.94
0
2025-Q1
Unchanged
5.9M
0.0%
$3.2M0.2%$10.82
0
2024-Q4
Unchanged
5.9M
0.0%
$3.8M0.2%$12.42
0
2024-Q3
Unchanged
5.9M
0.0%
$8.1M0.4%$30.20
0
2024-Q2
Unchanged
5.9M
0.0%
$8.5M0.4%$29.00
0

Other major holders of LYEL: HHLR ADVISORS, LTD., BlackRock Finance, Inc., PRICE T ROWE ASSOCIATES INC /MD/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used